Investor List:

Top Pharmaceuticals Series B Investors in Washington, D.C. (7)

Know someone who's actively diligencing and investing? Add them to this list.
About this list
We’ve compiled a list of the top Pharmaceuticals investors. The goal is to help Founders find the best investors to target and get introduced to.
Photo of Ali Behbahani, General Partner at New Enterprise Associates (NEA)
Ali Behbahani
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Ed Mathers, Partner at New Enterprise Associates (NEA)
Ed Mathers
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Maryland, Investors in Washington (DC)
Photo of Justin Klein, Managing Partner at Vensana Capital
Justin Klein
Vensana Capital·Managing Partner
Sweet spot: $1M
Range: $100K - $10.0M
Investors in Washington (DC)
Photo of Scott Gottlieb, Partner at New Enterprise Associates (NEA)
Scott Gottlieb
Sweet spot: $25.0M
Range: $2.0M - $50.0M
Investors in Washington (DC)
Photo of Sara Nayeem, Partner at Avoro Ventures
Sara Nayeem
Sweet spot: $1M
Range: $100K - $10.0M
Investors in New York City, Investors in Washington (DC)
Photo of Andrea Noda, Vice President at Arnold Venture Group
Andrea Noda
Arnold Venture Group·Vice President
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Washington (D.C.)
Photo of Andrew Lee, Senior Associate at Northpond Ventures
Andrew Lee
Northpond Ventures·Senior Associate
Sweet spot: $10
Range: $1 - $40
Investors in Washington (D.C.), Investors in San Francisco (CA)
Investors in Chemicals (Seed), Investors in Drug Delivery (Seed), Investors in Diagnostics (Seed), Investors in Drug Delivery (Seed), Investors in Chemicals (Seed), Investors in AgTech (Seed), Investors in Drug Delivery (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in Chemicals (Seed), Investors in BioTech (Seed), Investors in AgTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Diagnostics (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in AgTech (Seed), Investors in BioTech (Seed), Investors in Chemicals (Series A), Investors in Drug Delivery (Series A), Investors in Drug Delivery (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in AgTech (Series A), Investors in Drug Delivery (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in Chemicals (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Diagnostics (Series A), Investors in BioTech (Series A), Investors in AgTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Chemicals (Series B), Investors in Drug Delivery (Series B), Investors in Chemicals (Series B), Investors in AgTech (Series B), Investors in Drug Delivery (Series B), Investors in Diagnostics (Series B), Investors in Pharmaceuticals (Series B), Investors in Drug Delivery (Series B), Investors in BioTech (Series B), Investors in Chemicals (Series B), Investors in Diagnostics (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Diagnostics (Series B), Investors in BioTech (Series B), Investors in AgTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Washington, D.C. (Other Lists), Investors in Diverse Investors (Other Lists), Investors in Investors who invested in female founders (Other Lists), Investors in Investors who invested in diverse founders (Other Lists), Investors in San Francisco Bay Area (Other Lists)
Get new data & insights delivered to your inbox